--- title: "Gastro Intestinal, Endocrine, Nutrition & Blood Generic Medicines" ocid: "ocds-r6ebe6-0000576809" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000576809" markdown_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000576809.md" json_url: "https://d3tenders.com/contract/ocds-r6ebe6-0000576809.json" source: "Public Contracts Scotland" current_stage: "Award" buyer: "THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (\"NSS\")" published: "2019-08-15" --- # Gastro Intestinal, Endocrine, Nutrition & Blood Generic Medicines Buyer: THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS") Current stage: Award OCID: ocds-r6ebe6-0000576809 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000576809) [Download OCDS JSON](https://d3tenders.com/contract/ocds-r6ebe6-0000576809.json) ## Summary The procurement process is led by The Common Services Agency, also known as NHS National Services Scotland (NSS), located at Gyle Square, Edinburgh. The tender, titled "Gastro Intestinal, Endocrine, Nutrition & Blood Generic Medicines," falls under the health industry category, with an estimated contract value of approximately £33.36 million and spans a duration of 23 months, with a possible 24-month extension. The procurement method utilised is an open procedure, and the tender period concluded on 18 April 2019, marking the transition to the award stage. This framework agreement creates substantial opportunities for suppliers in the pharmaceutical sector, particularly those offering generic medicines related to gastroenterology, endocrinology, nutrition, and blood health. Businesses with relevant capabilities in producing or distributing such pharmaceuticals will find themselves well-positioned to compete. With a multi-supplier framework structure, successful bidders can anticipate secured contracts across various product lines, fostering long-term partnerships with NHS Scotland. ## Notice This Framework Agreement is for the supply of a range of Gastro Intestinal, Endocrine, Nutrition & Blood Generic Medicines to NHS Scotland. The Goods have been separated into ten (10) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice. ### Lot Information Lot 1 Desferrioxamine Injections Supply of Desferrioxamine Injections to NHS Scotland in a range of presentations. The Authority intends awarding all presentations within this lot to a single supplier. Full details can be found within the ITT. Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 2 Dexamethasone Injections The Supply of Dexamethasone Injections to NHS Scotland in a range of presentations. The Authority intends to award each product line as a multi-supplier unranked framework agreement and it is envisaged a maximum of 6 suppliers will be awarded. Full details can be found within the ITT. Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 3 Macrogol Oral Powder & Solutions The Supply of Macrogol Oral Powder & Solutions to NHS Scotland in a range of presentations. The Authority intends to award each product line as a multi-supplier unranked framework agreement and it is envisaged a maximum of 6 suppliers will be awarded. Full details can be found within the ITT. Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 4 Mesalazine The Supply of Mesalazine to NHS Scotland in a range of presentations. The Authority intends to award each product line as a multi-supplier unranked framework agreement and it is envisaged a maximum of 6 suppliers will be awarded. Full details can be found within the ITT. Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 5 Magnesium Sulfate The supply of Magnesium sulfate to NHS Scotland in a range of presentations. The Authority intends to award each product line as a multi-supplier unranked framework agreement and it is envisaged a maximum of 6 suppliers will be awarded. Full details can be found within the ITT. Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire Lot 6 Calcium Carbonate Tablets The Supply of Calcium Carbonate Tablets to NHS Scotland in a range of presentations. The Authority intends to award each product line as a multi-supplier unranked framework agreement and it is envisaged a maximum of 6 suppliers will be awarded. Full details can be found within the ITT. Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire Lot 7 Budesonide The supply of Budesonide to NHS Scotland in a range of presentations. The Authority intends to award each product line as a multi-supplier unranked framework agreement and it is envisaged a maximum of 6 suppliers will be awarded. Full details can be found within the ITT. Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 8 Vitamin with minerals and trace elements The supply of Vitamin with minerals and trace elements to NHS Scotland in a range of presentations. The Authority intends to award each product line as a multi-supplier unranked framework agreement and it is envisaged a maximum of 6 suppliers will be awarded. Full details can be found within the ITT. Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 9 - Pancreatin The supply of Pancreatin to NHS Scotland in a range of presentations. The Authority intends to award each product line as a multi-supplier unranked framework agreement and it is envisaged a maximum of 6 suppliers will be awarded. Full details can be found within the ITT. Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. Lot 10 All Other Presentations Supply of all other products/presentations within this tender to NHS Scotland. Each product line will be treated as an individual lot and awarded to a single supplier Participant. Full details of Goods and volumes can be found within the ITT documents. Renewal: Option to extend by a further two (2) periods of up to twelve (12) months each, each, upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire. ## Key Details | Field | Value | | --- | --- | | Publication source | Public Contracts Scotland | | Latest notice | https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG363475 | | Notice type | OJEU - F3 - Contract Award Notice | | Procurement type | Framework | | Procurement category | Goods | | Procurement method | Open | | Procurement method details | Open procedure | | Tender suitability | Not specified | | Awardee scale | Large | | All stages | Tender, Award | ## Dates | Field | Value | | --- | --- | | Publication date | 15 Aug 2019 | | Submission deadline | 18 Apr 2019 | | Future notice date | Not specified | | Award date | 16 Jul 2019 | | Contract period | Not specified | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | £33,357,901 | | Lots value | £33,357,903 | | Awards value | Not specified | | Contracts value | £24,562,617 | ## Status | Field | Value | | --- | --- | | Tender status | Complete | | Lots status | Complete | | Awards status | Unsuccessful | | Contracts status | Active | ## Buyer | Field | Value | | --- | --- | | Main buyer | THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS") | | Locality | EDINBURGH | | Post town | Edinburgh | | Postcode | EH12 9EB | | Country | Scotland | | ITL 1 | TLM Scotland | | ITL 2 | TLM1 East Central Scotland | | ITL 3 | TLM13 City of Edinburgh | | Local authority | City of Edinburgh | | Electoral ward | Drum Brae/Gyle | | Westminster constituency | Edinburgh South West | | Delivery location | TLM Scotland | ## Supplier | Field | Value | | --- | --- | | Number of suppliers | 39 | | Supplier names | ACCORD; ALLERGAN; AVENTIS PHARMA LTD TRADING AS SANOFI; BOWMED IBISQUS; BROWN AND BURK; CHIESI; CREO PHARMA; CRESCENT PHARMA; DR FALK PHARMA; DR REDDY'S LABORATORIES (UK; ENNOGEN HEALTHCARE; FERRING PHARMACEUTICALS; FOCUS PHARMACEUTICALS; GALEN; GLENMARK PHARMACEUTICALS EUROPE; GSK; HAMELN PHARMACEUTICALS; INTRAPHARM LABORATORIES; KENT PHARMACEUTICALS; KYOWA KIRIN; MARTINDALE PHARMA; MERCURY PHARMACEUTICALS; MORNINGSIDE PHARMACEUTICALS; MYLAN UK HEALTHCARE; NORGINE PHARMACEUTICALS; PANPHARMA; PFIZER; RANBAXY (UK; RB UK COMMERCIAL; ROSEMONT PHARMACEUTICALS; SANDOZ; SELECTIVE SUPPLIES; SHIRE PHARMACEUTICALS; SYRI LIMITED T/A THAME LABORATORIES; TEVA; THORNTON & ROSS; TILLOTTS PHARMA; TYPHARM; WOCKHARDT | ## CPV Codes ### Divisions - 33 - Medical equipments, pharmaceuticals and personal care products ### Codes - 33600000 - Pharmaceutical products ## Release History - 15 Aug 2019 at 00:00 - Award - OJEU - F3 - Contract Award Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG363475 - 15 Mar 2019 at 00:00 - Tender - OJEU - F2 - Contract Notice - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAR348631 ## Documents - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=MAR348631 Gastro Intestinal, Endocrine, Nutrition & Blood Generic Medicines - This Framework Agreement is for the supply of a range of Gastro Intestinal, Endocrine, Nutrition & Blood Generic Medicines to NHS Scotland. The Goods have been separated into ten (10) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice. - https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=AUG363475 Gastro Intestinal, Endocrine, Nutrition & Blood Generic Medicines - This Framework Agreement is for the supply of a range of Gastro Intestinal, Endocrine, Nutrition & Blood Generic Medicines to NHS Scotland. The Goods have been separated into ten (10) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice. ## Notice URLs - http:// - http://www.nhsscotlandprocurement.scot.nhs.uk/ - https://api.publiccontractsscotland.gov.uk/v1/Notice?id=ocds-r6ebe6-0000576809 - https://www.publictendersscotland.publiccontractsscotland.gov.uk - https://www.publictendersscotland.publiccontractsscotland.gov.uk/web/login.html ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-r6ebe6-0000576809. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-r6ebe6-0000576809.json.